Articles Archives - Page 35 of 724

TuesdayFeb 25, 2025 11:52 am

QualityStocksNewsBreaks – Twin Hospitality Group Inc. (NASDAQ: TWNP) Completes Spinoff from FAT Brands Inc. (NASDAQ: FAT)

Twin Hospitality (NASDAQ: TWNP), the owner of the Twin Peaks and Smokey Bones restaurant brands, has completed its spinoff from FAT Brands (NASDAQ: FAT), a leading global franchising company and parent company of 18 iconic brands. In conjunction with the spin-off, Twin Hospitality Class A Common Stock began trading under the symbol TWNP on the Nasdaq Global Market. Roth Capital Partners acted as financial advisor for the transaction. For more information, visit https://ibn.fm/q7xjN About Twin Peaks Founded in 2005 in the Dallas suburb of Lewisville, Twin Peaks franchises and owns 115 restaurants in the United States and Mexico. Twin Peaks…

TuesdayFeb 25, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Drives Growth with Strengthened Financial Position and Cutting-Edge Research

One of the most significant challenges facing biotechnology companies is securing adequate funding to sustain research and development efforts. Calidi’s improved financial footing reassures investors and allows the company to focus on achieving key milestones in its research pipeline. The company has been selected to present new data on its RTNova systemic virotherapy platform at the prestigious AACR annual meeting in April 2025. Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company, is making significant strides in the field of cancer immunotherapy. Known for its innovative approach to antitumor virotherapies, Calidi is focused on harnessing the power of its patented…

TuesdayFeb 25, 2025 10:45 am

How Adageis Simplifies Value-Based Care, Boosting Revenue for Healthcare Providers

Adageis streamlines complex insurance contracts, helping providers maximize reimbursements. The company’s AI-driven solutions reduce administrative burden, freeing up time for patient care. Seamless integration with nearly 100 EHR systems ensures a smooth transition to value-based care models. The company’s fintech approach enhances financial performance, with providers seeing up to $75,000 in additional revenue. Adageis projects significant growth, expecting to cover 580,000 patient lives by mid-2025. Healthcare is shifting toward value-based care, where providers are reimbursed for patient outcomes rather than the number of procedures performed. While the model promises higher-quality care at lower costs, it also introduces complex reimbursement structures…

TuesdayFeb 25, 2025 10:00 am

East Coast Cannabis Industry Gets Ready for the New England Cannabis Convention in Boston

Traders, dealers, businesses, and enthusiasts of the cannabis industry are invited to attend the New England Cannabis Convention in Boston from March 21 to March 22, 2025. Operating since 2015, NECANN events are referred to as “MJBizCon East.” The second largest B2B event in the U.S., NECANN witnesses thousands of attendees, with the largest gathering of licensed operators, exhibitors, buyers, and leaders, for the East Coast cannabis market. These events are considered the home base for the Northeast cannabis industry. The Boston NECANN Convention 2025 will also host the prize-giving ceremony for the Boston NECANN Cup winners on March 22,…

MondayFeb 24, 2025 1:00 pm

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Sees Growth, Potential in Oncology Drug Development, a Critical Frontier in Cancer Treatment

According to the American Cancer Society, cancer is the second leading cause of death globally. Oncology drugs are a cornerstone of modern cancer treatment. Calidi Biotherapeutics is a cutting-edge biotechnology company dedicated to developing innovative cancer treatments. Cancer continues to be one of the most significant health challenges of our time, with its global impact growing every year. The increasing number of cancer diagnoses and related deaths underscores the urgent need for more effective treatments, including advanced oncology drugs. Companies such as Calidi Biotherapeutics (NYSE American: CLDI) are at the forefront of research and development, offering hope for millions of…

MondayFeb 24, 2025 12:15 pm

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Reports Substantial Revenue, Gross Profit Growth, with Key Developments Painting Positive Outlook

The company’s six-month revenue reached $20.1 million CAD ($14.15 million USD), reflecting steady long-term growth despite seasonal fluctuations. Gross profit margin increased to 29.2%, up from 18.4% in the prior year, signaling improved margins. Assets surged 372% to $185.3 million CAD ($130.47 million USD) during the six month period, following the acquisition of Solar Flow-Through Funds Ltd. Recent $70.3 million CAD ($49.5 million USD) deal with Qcells will drive revenue in upcoming quarters. Share price more than doubled in early February, signaling investor interest. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier…

FridayFeb 21, 2025 12:15 pm

Massimo Group (NASDAQ: MAMO) Relocates MVR Golf Cart Production to Texas Amid Trade Tariffs

Manufacturing within the U.S. offers numerous benefits that can significantly impact a company's operational efficiency and market competitiveness The Massimo Group's recent announcement highlights the company's proactive approach in leveraging these benefits "We are committed to providing our customers with the highest quality golf carts while ensuring long-term business sustainability," states the CEO In recent years, manufacturing goods in the United States has become increasingly advantageous for companies aiming to enhance quality control, reduce lead times and navigate complex international trade dynamics. Recent tariff announcements have made the move to U.S. soil even more compelling. Massimo Group (NASDAQ: MAMO), a…

FridayFeb 21, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Focuses Innovation on Hard-to-Treat Tumors

As cancer numbers grow, Calidi Biotherapeutics is at the forefront of developing novel treatments aimed at improving patient outcomes. Calidi’s platform centers on the use of antitumor virotherapies that selectively infect and kill cancer cells while activating the body’s own immune system to attack the tumor. The company’s therapeutic pipeline targets multiple cancer indications, with a focus on hard-to-treat tumors. Cancer remains a significant global health challenge, with certain types exhibiting particularly high mortality rates. Glioblastoma multiforme (“GBM”), triple-negative breast cancer (“TNBC”), sarcoma and lung cancer are among the most aggressive and deadly forms, necessitating urgent advancements in research and…

FridayFeb 21, 2025 10:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Qubits 2025 Conference to Showcase ‘Quantum Realized’ Across Scientific Achievements, Technical Advancements and Commercial Applications

D-Wave’s Qubits 2025 quantum computing user conference will be held in Scottsdale, Arizona, March 31 and April 1, as well as a virtual livestream of the first day’s talks. The event will feature presentations from D-Wave executives, customers and industry thought leaders, highlighting product and technical roadmap updates, scientific advancements, the intersection of quantum and AI, and more. Presentations will showcase how the company’s quantum technology is delivering tangible value today. D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first supplier of production-grade quantum computers, announced that its Qubits 2025 quantum…

FridayFeb 21, 2025 10:00 am

How Adageis’ ProActive Care Approach Puts Patients First While Boosting Provider Revenue

Shifting to value-based care improves patient outcomes and cost-effective provider efficiency. Adageis’ ProActive Care shifts focus from reactive treatment to preventive, patient-centered care, with AI-driven analytics identifying high-risk patients and addressing care gaps. Patients receive more personalized, effective treatment, rather than a volume treatment driven approach. Better patient outcomes lead to reduced hospitalizations and cost savings, while increased cost monitoring and efficiency for providers supports increased revenue and net income potential. For many patients, the American healthcare system often feels rushed, transactional and fragmented. Doctors have limited time, and treatment decisions can be driven by billing structures rather than patient…

Site Search

Company Search

Category: Articles